Unbiased financial chart thread!, page-8

This calculation could be wrong as it is getting late, but here goes.
They are expecting outflows of $9.8M
From the half yearly operational expenses are relatively stable around $6m for the half (not including cost of sales) so for this quarter can we assume $6.8M in production costs.
If we are running on 30% gross margins this should give revenue of $9.71M (not sure what cash receipts will be, $2m difference invoiced but not received by last 4c).
That to me is getting close to cash flow neutral.

Other things to put the icing on the cake could include (highlighted in the Dec quarterly), licence agreements (at least 2 multi billion dollar chemical companies) for Alexiflam SYN and NF.
Potential exclusivity or licence deal for polymers and resins.
US defence
Tent manufacturer in China.
Growth in Europe expected to be comparable to North America.
6 additional suppliers to the bedding mattress sector.
Followed up with inner & outer ware garments expected released in the 2nd half of 2017.